Smiths Group PLC
27 September 2006
Smiths wins $71 million US Government contract for explosives detectors
SMITHS Detection, part of the global technology business Smiths Group, today
announces it has won a contract to supply explosives trace detectors (ETD) to
the US Government with a potential value of $71 million.
The Transportation Security Administration (TSA), part of the US Department of
Homeland Security, will deploy the Smiths Detection IONSCAN 400B desktop
explosives trace detectors at airports across the United States.
The TSA, which protects America's airports and rail network, has already made
its first purchase under the contract placing a $7.2 million order for IONSCAN
400B machines.
The detectors will be used to scan carry-on and checked baggage for traces of
explosives.
Stephen Phipson, Group Managing Director of Smiths Detection, said: 'We are
delighted to be able to provide equipment that can contribute greatly to the
detection of threats against the travelling public.
'There are already around 4,000 Smiths IONSCAN explosives trace detectors
deployed at airports in the United States. This contract is recognition of our
technological leadership in the global effort to keep transport systems safe.'
Smiths hand-held explosives detectors are already being used by the New York
Police Department to protect the subway and were involved in high-profile
security trials on the London Underground this year.
Smiths walk-through explosives detection portals are currently deployed at 17 US
airports, including JFK, Washington Dulles and Newark, and were recently
deployed by HM Revenue and Customs at Heathrow and Manchester airports to detect
narcotics.
The IONSCAN 400B is an explosives trace detector that can detect and identify
traces of more than 40 substances in eight seconds.
The desktop unit quickly analyses sample swabs of items such as handbags and
briefcases. The swab sample is then placed into the IONSCAN 400B for analysis
and the results are displayed to the operator.
A detection of trace explosives indicates that an explosive device may be
present or that the person may have been handling explosive material and further
investigation is necessary.
ENDS
IONSCAN is a trade mark of Smiths Detection
Smiths Group
Smiths is a global technology business, listed on the London Stock Exchange.
Smiths Group is a world leader in the practical application of advanced
technologies. Our products and services make the world safer, healthier and
more productive. Smiths Group has four divisions: Aerospace, Detection, Medical
and Specialty. It employs 32,000 people and has over 250 major facilities in 50
countries. For more information visit www.smiths-group.com
Smiths Detection
Smiths Detection is one of four operating divisions of Smiths Group. Smiths
Detection offers technologically advanced security solutions to detect and
identify explosives, chemical and biological agents, weapons, and contraband,
plus specialist applications for life sciences and food manufacturing
industries. Employing trace detection technology together with Smiths-Heimann
x-ray imaging, Smiths Detection provides security solutions for customers in
homeland security and defense markets worldwide. For further information visit
www.smithsdetection.com
Investor Relations Media
Russell Plumley Chris Fox
+44 (0)20 8457 8203 +44 (0)20 8457 8403
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.